| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/16/2003 | WO2002007774A3 Methods for therapy of neurodegenerative disease of the brain |
| 01/16/2003 | WO2002002783A3 Expression vectors |
| 01/16/2003 | WO2002002772A3 Human extracellular matrix (ecm)-related tumor marker |
| 01/16/2003 | WO2001092549A3 Method and composition for targeting an adenoviral vector |
| 01/16/2003 | WO2001091739A3 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001072833A3 Human ephrin-like receptor |
| 01/16/2003 | WO2001064880A9 Human dynamin 40322 |
| 01/16/2003 | WO2001058954A9 Trade molecules and uses related thereto |
| 01/16/2003 | WO2001058946A9 Polynucleotides and polypeptides encoded thereby |
| 01/16/2003 | US20030013867 Translation enhancer element of the human amyloid precursor protein gene |
| 01/16/2003 | US20030013674 Gene therapy; in situ supplying of genes; nucleic acid complex |
| 01/16/2003 | US20030013672 Biologically active metal-containing nucleic acids |
| 01/16/2003 | US20030013670 Antisense oligonucleotide inhibition of ras |
| 01/16/2003 | US20030013668 Antiarthritic agents; inflammatory bowel disease; multiple sclerosis |
| 01/16/2003 | US20030013644 Complexing; therapy for genetic defects |
| 01/16/2003 | US20030013636 Prevent biosynthesis of galactoside |
| 01/16/2003 | US20030013196 Expression vector for use as tools in genetic engineering and gene therapy |
| 01/16/2003 | US20030013195 Virus envelope vector for gene transfer |
| 01/16/2003 | US20030013191 Transgenic cells for use in human therapeutics and diagnostics |
| 01/16/2003 | US20030013190 Altered strain of the modified vaccinia virus ankara (mva) |
| 01/16/2003 | US20030013189 Noninvasive transfer of pharmocological agent into bloodstream; administer adenovirus to human, monitor response to pharmacological agent in lungs |
| 01/16/2003 | US20030013181 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 01/16/2003 | US20030013179 Enzymatic polypeptide for use in the treatment of lysosomal storage disorders |
| 01/16/2003 | US20030013161 Nucleotide sequences coding polypeptide for use in the treatment of cancer, allergies, autoimmune and inflammatory disorders |
| 01/16/2003 | US20030013152 Nucleotide sequences coding polypeptide for use in human therapeutics |
| 01/16/2003 | US20030013144 Detection of modulator of cancer activity; obtain sample containing biopolymers, incubate with modulator, monitor cellular response |
| 01/16/2003 | US20030013122 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/16/2003 | US20030013106 CCL1 polynucleotides and polypeptides and uses thereof |
| 01/16/2003 | US20030013097 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 01/16/2003 | US20030013095 Nuclcic acid enzyme for use in the prevention and treatment of infections and cancer |
| 01/16/2003 | US20030013087 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/16/2003 | US20030012812 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 01/16/2003 | US20030012781 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 01/16/2003 | US20030012772 Methods for improving cell line activity in immunoisolation devices |
| 01/16/2003 | US20030012770 Recombinant p53 adenovirus methods and compositions |
| 01/16/2003 | US20030012768 Connective tissue growth factor-2 |
| 01/16/2003 | US20030012767 Tissue-specific taanscriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector. |
| 01/16/2003 | CA2812821A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 01/16/2003 | CA2812799A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 01/16/2003 | CA2467006A1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | CA2453173A1 Mycobacterial antigens expressed during latency |
| 01/16/2003 | CA2453042A1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
| 01/16/2003 | CA2452980A1 Methods of administering vectors to synaptically connected neurons |
| 01/16/2003 | CA2452651A1 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 01/16/2003 | CA2452578A1 Ephrin and eph receptor mediated immune modulation |
| 01/16/2003 | CA2452119A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | CA2451741A1 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | CA2451087A1 Use of histamine receptor h3 gene in controlling body weight or food intake |
| 01/16/2003 | CA2451055A1 Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours |
| 01/16/2003 | CA2450020A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using dna sequences |
| 01/15/2003 | EP1275720A2 Histidyl-trna synthetase of staphylococcus aureus |
| 01/15/2003 | EP1275658A1 Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis |
| 01/15/2003 | EP1275398A1 Diagnostics and remedies for rheumatoid arthritis |
| 01/15/2003 | EP1274866A2 Diagnosis of diseases associated with metastasis |
| 01/15/2003 | EP1274865A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 01/15/2003 | EP1274862A1 Control of a gene induced by oxidized lipids in human artery wall cells |
| 01/15/2003 | EP1274861A1 Compositions and methods for identifying and targeting cancer cells |
| 01/15/2003 | EP1274854A2 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same |
| 01/15/2003 | EP1274853A1 Materials and methods relating to immune responses to fusion proteins |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274844A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274835A1 Human nim1 kinase |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274729A2 G protein coupled receptor |
| 01/15/2003 | EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274464A2 Compositions and methods for regulated protein expression in gut |
| 01/15/2003 | EP1274455A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
| 01/15/2003 | EP1274454A2 Methods and compositions for eliciting an immune response |
| 01/15/2003 | EP1274452A1 Method of preventing or treating diabetes |
| 01/15/2003 | EP1157105A4 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 01/15/2003 | EP0954222A4 Gene therapy for proliferative vitreoretinopathy |
| 01/15/2003 | EP0853450A4 Treatment of vascular injury |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/15/2003 | CN1391609A Use of replication-deficient adenoviral vector to boost CD8+T cell immune response to antigen |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391605A Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 01/15/2003 | CN1391479A Medicament for inducing tolerance |
| 01/15/2003 | CN1390936A Human atrial natriuretic peptide gene, its strong mutant and its application in treating relative diseases |
| 01/15/2003 | CN1098930C GRB3-3 gene, variants and uses thereof |
| 01/14/2003 | US6506891 Cell surface molecule-induced macrophage activation |
| 01/14/2003 | US6506890 Adding polycation to prevent aggregation; automatic |
| 01/14/2003 | US6506884 Variant of vascular endothelial growth factor |
| 01/14/2003 | US6506878 HMTF81 human 7-transmembrane receptor |
| 01/14/2003 | US6506735 Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences |
| 01/14/2003 | US6506604 Retroviral packaging system |
| 01/14/2003 | US6506596 Generating apoptotic bodies of somatic donor cells, incubating to allow for integration of DNA of the bodies into engulfing recipient cells |
| 01/14/2003 | US6506587 Nucleotide sequences coding enzymatic polypeptide; for use as an antitumor a gents |
| 01/14/2003 | US6506582 Extended by aspartic acid at 5' end and shortened at 3' end by one to eight amino acids; nonimmunogenic; binds CD4 lymphocytes |
| 01/14/2003 | US6506580 Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening |
| 01/14/2003 | US6506569 Drug screening; genetic engineering |
| 01/14/2003 | US6506550 Inducing apoptosis in cancer cells; drug screening for thiamine-depleting agents |
| 01/14/2003 | US6506408 Implantable or insertable therapeutic agent delivery device |
| 01/14/2003 | US6506379 Intramuscular delivery of recombinant AAV |
| 01/14/2003 | US6506378 Increasing efficiency of 3,4-dihydroxyphenylalanine conver-sion to dopamine; sequestering for sustained release; gene transfer modification of donor cells for grafting into central nervous system |
| 01/09/2003 | WO2003003016A1 Diagnostic methods and agents |
| 01/09/2003 | WO2003002765A2 Methods for the diagnosis of cancer based on the obcam and ntm genes |